Clinical trial
Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea
NCT00310323 · Virginia Commonwealth University, Other · Completed
Key facts
| NCT number | NCT00310323 |
|---|---|
| Title | Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea |
| Official title | Effect of Chronic Intermittent Nocturnal Hypoxia on Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea |
| Lead sponsor | Virginia Commonwealth University, Other |
| Collaborators | University of Louisville |
| Status | Completed |
| Study type | Interventional |
| Conditions | Sleep Apnea |
| Intervention type | Drug |
| Interventions | Dextromethorphan, Caffeine |
| Enrollment | 69 |
| Start date | Jan 1, 2003 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Apr 3, 2006 |
| Last update posted | Mar 19, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: